Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa pseudogene is a non-protein-coding genomic segment related in sequence to the functional NDUFB9 gene, which encodes a mitochondrial Complex I accessory subunit involved in electron transport[1][7]. This pseudogene does not produce a functional protein and has no established biological or pharmacological relevance. Pseudogenes generally arise from gene duplication or retrotransposition events and accumulate mutations that prevent their expression or function as a protein. Therefore, this gene is not considered a therapeutic target or associated with human disease. If you require information on the related functional gene NDUFB9 instead, please clarify—the NDUFB9 protein does contribute to the electron transport chain and has some clinical relevance, unlike its pseudogene[1][7].
None (drugs do not act on pseudogenes, but on their functional protein counterparts if present)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa pseudogene (None).